Rheumatoid arthritis Trials in Largo, United States
Conditions / Rheumatoid arthritis / Largo, United States
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00141830 | Study Evaluating ERB-041 With Methotrexate in Rheumatoid Arthritis | COMPLETED | PHASE2 |
| NCT00095147 | Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT02093026 | Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA) | COMPLETED | PHASE2 |
| NCT00853385 | A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01377012 | Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents | COMPLETED | PHASE3 |
| NCT00048581 | Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. | COMPLETED | PHASE3 |
| NCT00468546 | A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy | COMPLETED | PHASE3 |
| NCT00162266 | Abatacept With Methotrexate- Phase IIB | COMPLETED | PHASE2 |
| NCT00048932 | A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00124982 | Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy | COMPLETED | PHASE3 |